Inactive Instrument

Transcripts ImmunoGen, Inc.

Stocks

IMGN

US45253H1014

Biotechnology & Medical Research

Transcripts

23-11-02	ImmunoGen, Inc., Q3 2023 Earnings Call, Nov 02, 2023
23-07-31	ImmunoGen, Inc., Q2 2023 Earnings Call, Jul 31, 2023
23-05-03	ImmunoGen, Inc. - Special Call
23-04-28	ImmunoGen, Inc., Q1 2023 Earnings Call, Apr 28, 2023
23-03-01	ImmunoGen, Inc., 2022 Earnings Call, Mar 01, 2023
23-01-10	ImmunoGen, Inc. Presents at 41st Annual J.P. Morgan Healthcare Conference, Jan-08-2023 through Jan-12-2023
22-11-15	ImmunoGen, Inc. - Special Call
22-11-04	ImmunoGen, Inc., Q3 2022 Earnings Call, Nov 04, 2022
22-11-04	ImmunoGen, Inc. Provides Earnings Guidance for the Year 2022	CI
22-09-28	ImmunoGen, Inc. Presents at 2022 Guggenheim Nantucket Therapeutics Conference, Sep-28-2022 11:15 AM
22-08-31	ImmunoGen, Inc. - Special Call
22-07-29	ImmunoGen, Inc., Q2 2022 Earnings Call, Jul 29, 2022
22-06-09	ImmunoGen, Inc. Presents at 2022 Jefferies Global Healthcare Conference, Jun-09-2022 09:30 AM
22-05-24	ImmunoGen, Inc. Presents at H.C. Wainwright Global Investment Conference 2022, May-24-2022 07:00 AM
22-05-06	ImmunoGen, Inc., Q1 2022 Earnings Call, May 06, 2022
22-05-06	Immunogen, Inc. Provides Revenue Guidance for 2022	CI
22-03-20	ImmunoGen, Inc. - Special Call
22-02-25	ImmunoGen, Inc., 2021 Earnings Call, Feb 25, 2022
22-02-25	ImmunoGen, Inc. Provides Earnings Guidance for the Year 2022	CI
22-01-12	ImmunoGen, Inc. Presents at JPMorgan 40th Annual Healthcare Conference, Jan-12-2022 09:00 AM
21-11-30	ImmunoGen, Inc. - Special Call
21-10-29	ImmunoGen, Inc., Q3 2021 Earnings Call, Oct 29, 2021
21-10-29	ImmunoGen, Inc. Provides Updated Financial Guidance for 2021	CI
21-07-30	ImmunoGen, Inc., Q2 2021 Earnings Call, Jul 30, 2021
21-07-30	Immunogen, Inc. Maintains Revenue Guidance for the Year 2021	CI